ALK-Abelló A/S EBIT

As of the most recent data (June 2026), ALK-B.CO shows a EBIT of $1.8B. That compares with $1.4B in the prior-year period — up 32.7% year over year. That is below the Healthcare sector average of $110B. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, ALK-B.CO's EBIT is now $1.8B (was $1.4B) — a 32.7% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether ALK-Abelló A/S is outperforming or lagging.

The Healthcare sector average EBIT is about $110B. ALK-Abelló A/S is at $1.8B, which is lower that average. That is roughly 98.3% below the sector mean. Use the comparison chart on this page to see how ALK-B.CO stacks up against individual peers as well.

Tracking ALK-B.CO's ebit over time shows whether ALK-Abelló A/S is scaling, shrinking, or reshaping that part of the business. The current reading is $1.8B That compares with $1.4B in the prior-year period — up 32.7% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this ebit page, Stockcircle has ALK-Abelló A/S's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect EBIT (currently $1.8B) with ownership activity and broader fundamentals.